BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32941958)

  • 1. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
    Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
    Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy for sacral chordoma.
    Imai R; Kamada T; Sugahara S; Tsuji H; Tsujii H
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S48-54. PubMed ID: 21427182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
    Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
    Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature.
    Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
    Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
    Kinoshita H; Yonemoto T; Yamada S; Imai R
    Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.
    Aoki S; Koto M; Ikawa H; Imai R; Tokuhiko O; Shinoto M; Takiyama H; Yamada S; Tsuji H
    Head Neck; 2022 Oct; 44(10):2162-2170. PubMed ID: 35734902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
    Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
    Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.
    Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D
    World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
    Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
    Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
    Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
    Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
    Chung SY; Takiyama H; Kang JH; Chang JS; Min BS; Tsuji H; Yamada S; Koom WS
    Sci Rep; 2022 Feb; 12(1):1845. PubMed ID: 35115612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.